SCHEMBL13638376

SCHEMBL13638376

CNc1ccc2c(=O)n(-c3ccc(NC(=O)NCc4ccc(C)s4)cc3C(F)(F)F)c(=O)[nH]c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.40
GRIA1 P42261 7/20 0.37
GRIA2 P42262 7/20 0.37
GRIA3 P42263 7/20 0.37
GRIA4 P48058 7/20 0.37
ERCC1 P07992 1/20 0.37
FEN1 P39748 1/20 0.37
ERCC4 Q92889 1/20 0.37
GRIK1 P39086 5/20 0.37
GRIK2 Q13002 5/20 0.37
GRIK3 Q13003 5/20 0.37
GRIK4 Q16099 5/20 0.37
GRIK5 Q16478 5/20 0.37
P2RY12 Q9H244 1/20 0.37
CA9 Q16790 2/20 0.36
CA12 O43570 1/20 0.36
IDO1 P14902 1/20 0.35
RXFP1 Q9HBX9 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923275 0.92 P2RY12 (0.44) ARGRIA1GRIA2GRIA3GRIA4
SCHEMBL12177433 0.89 P2RY12 (0.41) ERCC1FEN1ERCC4P2RY12CA9
SCHEMBL12177436 0.89 ERCC1 (0.40) ERCC1FEN1ERCC4P2RY12CA9
SCHEMBL14113556 0.85 AR (0.40) ARERCC1FEN1ERCC4P2RY12
SCHEMBL14228647 0.84 P2RY12 (0.52) ARGRIA1GRIA2GRIA3GRIA4
SCHEMBL13182836 0.83 P2RY12 (0.40) ERCC1FEN1ERCC4P2RY12CA9
SCHEMBL9923272 0.82 P2RY12 (0.44) ERCC1FEN1ERCC4P2RY12CA9
SCHEMBL14228582 0.81 RXFP1 (0.38) ERCC1FEN1ERCC4P2RY12CA9
SCHEMBL9923013 0.81 P2RY12 (0.49) ERCC1FEN1ERCC4P2RY12CA9
SCHEMBL9923009 0.80 P2RY12 (0.44) ARGRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed